Clinical trial

A 12 Week Study of MK0653A in Patients Who Have Been Hospitalized for a Possible…

NCT00132717 · Organon and Co, Industry · Completed

Key facts

NCT number NCT00132717
Title A 12 Week Study of MK0653A in Patients Who Have Been Hospitalized for a Possible Heart Problem (0653A-808)
Official title An Open-Label, Multicenter Study to Assess the Efficacy of Switching to a Combination Tablet Ezetimibe/Simvastatin 10mg/40mg, Compared to Doubling the Dose of Statin in Patients Hospitalized With a Coronary Event
Lead sponsor Organon and Co, Industry
Status Completed
Phase Phase 3
Study type Interventional
Conditions Hypercholesterolemia
Intervention type Drug
Interventions MK0653A (ezetimibe [+] simvastatin), Comparator: atorvastatin, Comparator: fluvastatin, Comparator: lovastatin, Comparator: pravastatin, Comparator: rosuvastatin, Comparator: simvastatin
Enrollment 450
Start date Jan 1, 2005
Primary completion Jun 1, 2007
Completion Jun 1, 2007
First posted Aug 22, 2005
Last update posted Aug 15, 2024

At a glance

  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies